Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended-Reference-Cited by-同舟云学术

Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended

Published:2014-09-09 Issue:9 Volume:9 Page:e106250
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Huet Sarah,Cony-Makhoul Pascale,Heiblig Maël,Tigaud Isabelle,Gazzo Sophie,Belhabri Amine,Souche Denis,Michallet Mauricette,Magaud Jean-Pierre,Hayette Sandrine,Nicolini Franck

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference23 articles.

1. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;M Baccarani;Blood,2013

2. Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib;D Marin;Blood,2012

3. Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML);B Hanfstein;Leukemia,2012

4. Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS);TP Hughes;Blood,2010

5. Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib;TP Hughes;Blood,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variant‐specific BCR::ABL1 quantification discrepancy in chronic myeloid leukemia;International Journal of Laboratory Hematology;2024-06-05

2. Measurable residual disease in chronic myeloid leukemia;Haematologica;2022-12-01

3. Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia;Turkish Journal of Hematology;2022-08-24

4. Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels;Turkish Journal of Hematology;2022-08-24

5. Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia;Blood;2021-03-04